Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors
Igor A. Schepetkin(Montana State University), Mark T. Quinn(Montana State University)
Cited by 87
Related Papers
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists
|European Journal of Medicinal Chemistry|2013|49
Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1
|Journal of Molecular Modeling|2011|19